Single and Combined Neuroimaging Techniques for Alzheimer's Disease Detection.
Morteza AminiMir Mohsen PedramAli Reza MoradiMahdieh JamshidiMahshad OuchaniPublished in: Computational intelligence and neuroscience (2021)
Alzheimer's disease (AD) consists of the gradual process of decreasing volume and quality of neuron connection in the brain, which consists of gradual synaptic integrity and loss of cognitive functions. In recent years, there has been significant attention in AD classification and early detection with machine learning algorithms. There are different neuroimaging techniques for capturing data and using it for the classification task. Input data as images will help machine learning models to detect different biomarkers for AD classification. This marker has a more critical role for AD detection than other diseases because beta-amyloid can extract complex structures with some metal ions. Most researchers have focused on using 3D and 4D convolutional neural networks for AD classification due to reasonable amounts of data. Also, combination neuroimaging techniques like functional magnetic resonance imaging and positron emission tomography for AD detection have recently gathered much attention. However, gathering a combination of data can be expensive, complex, and tedious. For time consumption reasons, most patients prefer to throw one of the neuroimaging techniques. So, in this review article, we have surveyed different research studies with various neuroimaging techniques and ML methods to see the effect of using combined data as input. The result has shown that the use of the combination method would increase the accuracy of AD detection. Also, according to the sensitivity metrics from different machine learning methods, MRI and fMRI showed promising results.
Keyphrases
- machine learning
- big data
- deep learning
- convolutional neural network
- artificial intelligence
- magnetic resonance imaging
- electronic health record
- positron emission tomography
- computed tomography
- loop mediated isothermal amplification
- real time pcr
- label free
- cognitive decline
- contrast enhanced
- newly diagnosed
- ejection fraction
- mass spectrometry
- prognostic factors
- pet imaging
- brain injury
- mild cognitive impairment
- patient reported